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Abstract
Background: Carotenoids are pigment molecules produced mainly in plants and heavily exploited
by a wide range of organisms higher up in the food-chain. The fundamental processes regulating
how carotenoids are absorbed and metabolized in vertebrates are still not fully understood. We
try to further this understanding here by presenting a dynamic ODE (ordinary differential equation)
model to describe and analyse the uptake, deposition, and utilization of a carotenoid at the whole-
organism level. The model focuses on the pigment astaxanthin in Atlantic salmon because of the
commercial importance of understanding carotenoid dynamics in this species, and because
deposition of carotenoids in the flesh is likely to play an important life history role in anadromous
salmonids.
Results: The model is capable of mimicking feed experiments analyzing astaxanthin uptake and
retention over short and long time periods (hours, days and years) under various conditions. A
sensitivity analysis of the model provides information on where to look for possible genetic
determinants underlying the observed phenotypic variation in muscle carotenoid retention. Finally,
the model framework is used to predict that a specific regulatory system controlling the release of
astaxanthin from the muscle is not likely to exist, and that the release of the pigment into the blood
is instead caused by the androgen-initiated autolytic degradation of the muscle in the sexually
mature salmon.
Conclusion:  The results show that a dynamic model describing a complex trait can be
instrumental in the early stages of a project trying to uncover underlying determinants. The model
provides a heuristic basis for an experimental research programme, as well as defining a scaffold
for modelling carotenoid dynamics in mammalian systems.
Background
Carotenoids are conjugated double-bond pigment mole-
cules synthesized by plants and some bacteria, algae and
fungi. Their primary function in these organisms is to
absorb light during photosynthesis and to aid in photo-
protection [1]. They are classified by structure as carotenes
and xanthophylls, depending upon their oxygen and
hydrocarbon content. In the animal kingdom, caroten-
oids are heavily utilized as a source for pigmentation, as
vitamin A precursors, and probably also for improving
intercellular communication, enhancing immune
response, and as antioxidants in vivo [2,3]. There is still a
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limited understanding of the fundamental processes regu-
lating how carotenoids are absorbed and metabolized in
mammalian as well as non-mammalian systems. Here we
present a dynamic model to describe and analyse the
uptake, deposition, utilization and metabolism of a caro-
tenoid at the whole-organism level, Atlantic salmon
(Salmo salar) being the system chosen.
The carotenoid dynamics in Atlantic salmon is particu-
larly interesting because other marine fish species feeding
partly on the same prey in the same marine habitat do not
accumulate carotenoids in their muscle, while otherwise
having a very similar carotenoid uptake, metabolism and
utilization pattern [4,5]. A deeper understanding of how
metabolic systems are changed according to changes in
selection pressures is of considerable evolutionary inter-
est, since it links mechanistic and life-history reasoning
into more comprehensive evolutionary explanations. In
addition, a better understanding of carotenoid dynamics
is likely to be of substantial economic importance. In
Astaxanthin uptake, transport and deposition Figure 1
Astaxanthin uptake, transport and deposition. The figure illustrates our current understanding of the astaxanthin path-
way in salmonids. The uptake of astaxanthin from the intestine, transport in the blood and deposition in the muscle by the var-
ious lipoproteins is depicted. During sexual maturation/spawning migration (gray lines), the astaxanthin is redistributed from 
the muscle to the skin and gonads by the HDL.
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commercial salmon production, astaxanthin has proved
to be the most efficient carotenoid for muscle pigmenta-
tion [6,7], and synthetic astaxanthin is added to feeds in
order to make up for the lack of a natural dietary source of
the pigment. The retention of dietary carotenoids by the
muscle tissues varies from 2 – 22% in salmonid species
[6,7], and astaxanthin is responsible for 15–20% of the
total feed cost [8].
Even though a model describing the flow and deposition
of a carotenoid at the whole-organism level in salmonids
has to be specific, it is general enough to function as a scaf-
fold for modelling carotenoid dynamics in mammalian
systems. In this way it may contribute to improved under-
standing of the bioavailability of carotenoids in humans,
a trait of considerable importance to human health and
disease prevention [9].
Link between astaxanthin metabolism and fat metabolism
Two basic premises underlying the description to follow
are that (i) astaxanthin uptake, transport and delivery are
closely associated with fatty acid uptake, transport and
delivery, and (ii) major features of astaxanthin absorp-
tion, metabolism and transport in salmon are similar to
the absorption, metabolism and transport of xantho-
phylls in mammalian systems. There is some solid evi-
dence for this. Due to their hydrophobic nature,
carotenoids are known to be closely associated with fatty
acids and transported along with them through the intes-
tine and blood [10,11]. This seems also to be the case for
astaxanthin as radioactive studies show that it is associ-
ated with all the serum lipoproteins [12], which are the
main transporters of esterified fatty acids. Likewise, it is
also associated with serum albumin [12], the main trans-
porter of unesterified (or free) fatty acids in mammalian
systems [13,14]. Further, it has been found that pigmen-
tation in salmon is quite strongly affected by dietary fat.
Higher levels of astaxanthin deposition and retention in
rainbow trout [15] and Atlantic salmon [16] have been
obtained by increasing dietary lipid levels. This associa-
tion has been observed in humans as well, where ade-
quate dietary fat levels are necessary for optimal
carotenoid absorption [9].
Within this framework the presentation to follow is our
current understanding (or meta-hypothesis) of the flow
and fate of astaxanthin in Atlantic salmon (Figure 1), and
our mathematical model (see Methods) attempts to be a
representation of this understanding.
Uptake and transport into blood
Being fat-soluble, dietary astaxanthin is assumed to be in
micellar form in the intestine, together with bile salts,
fatty acids, monoglycerides and other fat-soluble vitamins
[17]. It is believed to passively diffuse into the intestinal
lumen, together with fatty acids [11], and the uptake
seems to be a slow process taking between 18 and 30
hours [18,19]. The fatty acids are converted into triacyl
glycerols (TAG), and the astaxanthin, like other xantho-
phylls [20], is incorporated together with TAGs in lipo-
protein spheres called chylomicrons. These are then
transported into the blood [21] and due to its polarity,
astaxanthin is assumed to be attached to the surface of the
chylomicron spheres [20].
In mammals, transport of chylomicrons from the intesti-
nal lumen into the blood is carried out through lymphatic
vessels. While being transported along the blood stream,
chylomicrons undergo hydrolysis by lipoprotein lipase
(LPL), a triacylglycerol lipase found on the surface of
endothelial cells of the tissue capillaries, to yield free fatty
acids. The fatty acids and monoglycerols that are derived
from chylomicrons in this way are subsequently taken up
by the tissues or serum albumin [22,23]. Changes in the
lipid composition of a chylomicron modify the affinity of
the associated lipoproteins for its surface, causing the chy-
lomicron to change its apolipoprotein signature [24].
When the chylomicrons have lost about 80% of their ini-
tial TAG content [22], they become small enough to pass
through the endothelium in the liver, and in addition
their apolipoprotein signature can then be recognized by
specific receptors in the liver [23].
The fate of chylomicron-associated xanthophylls is poorly
understood in mammals as well as in fish. It is hypothe-
sized that non-triglyceride components of the chylomi-
cron, including surface molecules such as xanthophylls,
may be taken up by extra-hepatic tissues or transferred to
other blood lipoproteins [3]. When the chylomicrons
reach the liver, however, they still contain a considerable
amount of their original carotenoid content [9,11].
Since fish do not seem to have a lymph system similar to
the mammalian one, the chylomicrons are assumed to be
transported through the primary blood vessels in the
intestine [25]. Aside from this, there is reason to assume
that chylomicron-based astaxanthin transport and deliv-
ery in salmon are quite similar to that in mammals, as dis-
cussed above.
Studies in salmon have provided evidence that astaxan-
thin is strongly associated with a protein likely to be
serum albumin [12,26]. We know that serum albumin
associates with the surface of lipoprotein particles [22],
and we also know that albumin is the major transporter of
free fatty acids released during lipolysis by LPL to tissues
(including liver and muscle) [13,22]. This suggests that
albumin may acquire astaxanthin from chylomicrons dur-
ing lipolysis as well as directly from chylomicrons in the
bloodstream.BMC Biology 2006, 4:10 http://www.biomedcentral.com/1741-7007/4/10
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Liver metabolism and excretion
The liver is the main metabolic and excretory organ for
carotenoids [27,28] and is considered to have the major
responsibility for the metabolic loss of astaxanthin [29].
The liver secretes bile into the intestine to aid in lipid
digestion as well as in the excretion of metabolic break-
down products, and radioactive labelling studies with
canthaxanthin [27] found bile radioactivity levels to be 8
times higher than the level in blood. The astaxanthin
metabolites in the bile are secreted into the intestine and
re-absorbed [28]. Radiolabeling experiments also indicate
that either astaxanthin or its metabolites are excreted by
the kidneys of salmon and rainbow trout [4,27]. The liver
is therefore either catabolizing astaxanthin to other pig-
ments or to metabolites that no longer have a chromo-
phore [29].
The exact process of astaxanthin metabolism in the liver is
unknown, as is the case with beta-carotene metabolism
[11]. We do know, however, that the chylomicron-deliv-
ered astaxanthin that is not metabolized is repackaged
into very low-density lipoproteins (VLDL) before being
sent out into the blood once more [24].
Transport and deposition in muscle
Despite numerous studies, the mechanism by which free
fatty acids enter cells remains poorly understood [30]. We
do know that through the action of LPLs in the tissue cap-
illary walls the VLDLs are broken down into low density
lipoproteins (LDLs) [23]. Astaxanthin association with
LDLs has been observed in salmon [12] and rainbow trout
[31], suggesting that astaxanthin-containing LDLs may
contribute substantially to the LPL-mediated uptake of
astaxanthin by circulating albumin. Astaxanthin is then
assumed to be brought to the muscle by circulating albu-
min [22]. Binding to the muscle cell wall is thought to be
non-specific and saturable [32].
After having entered the muscle cell, astaxanthin is depos-
ited in the myotome and binds to actomyosin by weak
hydrophobic bonds, forming a complex. The presence of
hydroxyl and keto groups at the β-end of the carotenoid
Astaxanthin plasma levels after a single feeding Figure 2
Astaxanthin plasma levels after a single feeding. The experimental data of Aas et al. plotted with the corresponding 
model-simulated results. The change in plasma level of astaxanthin over 72 hrs is shown, after a single feeding.
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increases the binding strength [33], explaining the higher
deposition of astaxanthin compared to other carotenoids
in salmon. Metabolites of astaxanthin have also been
found in the connective tissues between myotomes [28].
During VLDL and LDL flow through the blood, some of
the TAG found in these lipoproteins is transferred to high-
density lipoprotein packets (HDL) by the cholesteryl ester
transfer protein (CETP) [22,34]. Given that astaxanthin is
transported along with the TAGs to the HDLs, this mech-
anism is likely to explain the observed high levels of HDL-
associated astaxanthin in immature salmon [12], where
there is no pigment transport out of the muscle.
An interesting feature here is that unlike in mammalian
systems, Atlantic salmon muscle has been found to
express albumin [35]. Whether this has any significance
on astaxanthin retention/transport is yet to be deter-
mined.
Release from muscle
There is no detectable reduction in astaxanthin levels in
the flesh even after several weeks of starvation in the sex-
ually immature salmon [36,37]. Sexually maturing salmo-
nids, however, transfer flesh carotenoids to the skin and
gonads, and there is a prominent loss of whole-body car-
otenoids in this stage [38]. HDL seems to be the major
Table 1: Values of the model parameters
Relative rates Values (per day)
rhc – transfer from chylomicrons to remnants and albumin 0.5
rlc – uptake from chylomicron remnant to liver 5
rla – deposition in liver from albumin 1.2
rll – uptake into liver from LDL 5
rlh – uptake into liver from HDL 5
rld – enzymatic degradation and excretion in liver 0.5
rv – uptake by VLDL from liver 0.25
rhv – transfer from VLDL to LDL and albumin 0.5
rhvldl – uptake into HDL from VLDL 0.5
ral – uptake into albumin from LDL at muscle 0.05
rhldl – uptake into HDL from LDL 0.05
Rma – deposition in muscle from albumin 0.00024 mg·(ml blood)-1·day-1
rhm – transfer into HDL from muscle 0.03
rc – bioavailable fraction of astaxanthin fed 0.5
Tissue weight constants Values
b – blood volume as a fraction of fish weight 0.045 litre blood·(kg fish)-1
l – liver weight as a fraction of fish weight 0.01 kg liver·(kg fish)-1
m – muscle weight as a fraction of fish weight 0.50 kg muscle·(kg fish)-1
γ, λ, ρ – allometric constants 1
Sigmoid values Values
nma – Hill coefficient 2
θma – threshold 0.00005 mg·(ml blood)-1
Fractions taken up by albumin Values
φ – from chylomicrons 0.75
η – from VLDL 0.75
Convolution terms Values
µ1 – Mean of Iax 1
σ1 – Standard deviations of Iax 0.001
µ2 – Mean of Z 20
σ2 – Standard deviations of Z 12BMC Biology 2006, 4:10 http://www.biomedcentral.com/1741-7007/4/10
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transporter of astaxanthin from muscle to the skin [12]. In
female fish, astaxanthin is also transported from muscle
and the gastro-intestinal tract to the ovaries by the lipo-
protein vitellogenin, which is produced by the liver [39].
In the skin, the highest levels are found in the dorsal cutis,
indicating an association with the melanin that is found
there [28]. HDL has also been reported to transport astax-
anthin from the skin to the gonads and eggs [19]. In the
eggs it is bound to lipovitellin, the predominant egg yolk
lipoprotein derived from vitellogenin [40]. The eggs seem
to require a minimum level of astaxanthin in order to be
viable [41], though this is still under debate [42].
Results
Our current conception of carotenoid metabolism as illus-
trated in the previous section was translated into a differ-
ential equations model (see Methods). Model predictions
were then tested against available experimental data.
Single pulse feeding
After some preliminary calibration (see Methods) we first
tested whether the model was capable of mimicking the
temporal blood level pattern of astaxanthin observed in a
single pulse feeding experiment conducted by Aas et al.
[12]. In this experiment Atlantic salmon weighing 700 g
were force fed a single dose of 14C-astaxanthin and the
radioactivity level in the blood was measured over a 72
hour period. The total blood level peaked around 30 hrs,
with contributions from the various lipoprotein fractions
as well as a high-density protein fraction (~57.7%)
assumed to be albumin. In the simulation the weight of
the fish and hence the tissue weights were kept constant.
Although the parameter freedom in this first simulation is
considerable, it is still encouraging that the model proved
able to mimic the experimental data quite well at such a
high time resolution (Figure 2).
Long-term interval feeding
The model was then expanded to predict astaxanthin
accumulation in the flesh over a much longer time span (>
Muscle uptake at different dietary concentrations of astaxanthin Figure 3
Muscle uptake at different dietary concentrations of astaxanthin. The experimental data of March et al. plotted with 
the corresponding model-simulated results. The muscle astaxanthin concentrations after a period of 40 weeks of feeding astax-
anthin at dietary levels of 40, 70 and 100 mg/kg feed are shown.
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1 year), with constant interval feeding and accounting for
the associated weight increase of tissues. Except for time
scale adjustments, the same set of parameter values was
used as in the previous case (see Table 1). We chose a feed
study done by March and Macmillan [43] as our experi-
mental test bed. In this experiment development of the
carotenoid level in the flesh of Atlantic salmon was stud-
ied as a function of different dietary levels of astaxanthin
(40, 70 and 100 mg/kg feed) over a period of 40 weeks. It
was observed that when fish of initial weight 200 g were
fed for 40 weeks, the pigment level in the muscle showed
clear signs of saturation as a function of the astaxanthin
level in the food. Even though we did not change any of
the parameter values made use of in the single pulse feed-
ing experiment, the model was able to mimic the tempo-
ral astaxanthin concentration in the flesh as well as the
saturation effect quite neatly (Figure 3).
Quasi-steady state sensitivity analysis
A sensitivity analysis of the model was performed in order
to identify which processes described in the model were
the least robust to changes in parameter values. The actual
system is non-autonomous due to the time-dependent
weight w, but due to the slow increase of w compared to
the time-scales of feeding and metabolism, we assumed in
the analysis that the system is close to its quasi steady state
(QSS) at any time. The rationale for this analysis is that it
discloses which parameter values are really influencing
the quantitative predictions of the model. If these param-
eter values are not experimentally well confined, one
Sensitivity analysis of the model to variation in parameters – QSS Figure 4
Sensitivity analysis of the model to variation in parameters – QSS. Plots of the sensitivity of the muscle uptake rate 
MUR to variation in the log of key parameters of the model equations; sensitivity to variation in rate of uptake into chylomi-
crons from intestine, rc (A), rate of deposition in the liver by albumin, rla (B), rate of deposition in the liver by LDL, rll (C), rate 
of metabolic degradation in the liver, rld (D), rate of uptake into the muscle from albumin, Rma (E) and the threshold of satura-
tion in the muscle, θma (F). The values of these parameters are relative to the values given in Table 1.
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needs to estimate them more accurately by experimental
means before one can claim that the model provides a
good representation of the system under study.
The analysis shows that the uptake in the muscle (MUR)
is most sensitive to changes in the rate of deposition of
albumin-bound astaxanthin (rma), as well as to the thresh-
old of saturation (θma) (Figure 4). The uptake and degra-
dation in the liver (rla,  rll,  rld) does not seem to affect
muscle deposition to any significant extent. Though the
muscular uptake seems to be proportional to the intesti-
nal uptake (rc), this is the case only until it saturates, at
which point increasing the uptake from the intestine
would not have any effect on the uptake in the muscle.
Assuming that the model provides a good representation
of the underlying biology, such an analysis is also a means
of finding possible sites where the system is sensitive to
genetic variation. In this case, the results suggest that
genetic variation associated with processes influencing the
uptake rate of astaxanthin over the muscle membrane
seems to be of particular importance.
Time-series sensitivity analysis
The parameters of the model were analysed for sensitivity
using the data from the single pulse feeding experiment
[12] to determine which of the parameters affect the
dynamics of the model output. Given the large freedom in
possible parameter values, this analysis mainly focused on
Sensitivity analysis of the model to variation in parameters – Time-series Figure 5
Sensitivity analysis of the model to variation in parameters – Time-series. (A) – Boxplot of the selected 1,264 
parameter sets out of the total 50,000, which have values giving a total sum of squared deviation of 30% or less from the exper-
imental data, as well as a relative deviation of 50% or less at each individual experimental time point. (B) – Distribution of 
parameter µ2 for the 1264 selected parameter sets. (C) – Distribution of the ratio µ2/rc for the 1,264 selected parameter sets 
(bars, left y-axis) as well as the distribution of the ratio for all 50,000 parameter sets (curve, right y-axis). (D) – Distribution of 
the ratio µ2/σ2 for the 1,264 selected parameter sets (bars, left y-axis) as well as the distribution of the ratio for all 50,000 
parameter sets (curve, right y-axis).
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finding out whether the parameters had to lie within a cer-
tain range in order to obtain a good fit with the experi-
mental data.
The analysis shows that the most influential parameters,
i.e. those having the smallest range of values which give a
good fit, are those determining the time delay occurring
during intestinal uptake of astaxanthin (mean µ2 standard
deviation σ2 of the integral kernel, see Methods) and the
bioavailable fraction of astaxanthin (rc)(Figure 5A). This
is to be expected as the time and rate at which the astaxan-
thin enters the blood stream and hence the time at which
the blood astaxanthin concentration peaks are dependent
on these three parameters. The rest of the parameters have
a more uniform range, indicating that the model is quite
robust to small changes in their values.
The interaction between the three selected parameters was
then analysed further by determining the distribution of
their ratios. There is a clear narrowing in the range of pos-
sible values (Figures 5B, 5C, 5D) which will produce a
curve that fits the data well.
Regulatory control of astaxanthin release from the 
muscle?
During the spawning migration the astaxanthin stored in
the flesh is redistributed to the skin and ovaries in female
fish and to the skin in males [38,44]. There is no doubt
that the astaxanthin release from the muscle is directly or
indirectly under hormonal influence as sexual immature
salmon do not release astaxanthin to the blood even when
they are starved for several weeks [36,37]. It has to be
decided, however, whether this release is under specific
regulatory control or not, i.e. does the salmon possess a
specific regulatory apparatus responsible for the release of
astaxanthin from its actomyosin binding sites and its sub-
sequent transport to and through the muscle membrane
to the blood?
Astaxanthin redistribution induced by sexual maturation Figure 6
Astaxanthin redistribution induced by sexual maturation. Model prediction of the redistribution of astaxanthin from 
the muscle to the skin and gonads in male and female fish during sexual maturation and spawning migration. Simulations were 
performed for a period of 100 days of starvation, i.e. no input feeding and tissue weight loss.
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Based on available data on the muscle degradation rate of
salmon during migration and spawning [45], we devel-
oped a modified version of the model presuming that the
release of astaxanthin from the muscle to the blood is pro-
portional to the muscle degradation rate, as obtained
from literature [46]. No input astaxanthin was given in the
simulations and the initial muscle concentration was set
to that obtained after simulating a year of feeding. We
found that the release rate of astaxanthin due to muscle
degradation can account for observed release of astaxan-
thin in sexually mature salmon (Figure 6). We therefore
predict that a specific regulatory system controlling the
release of astaxanthin from the muscle does not exist. The
release of the pigment into the blood is according to this
hypothesis a side effect of androgen-initiated autolytic
degradation of the muscle [47]. Having entered the blood
stream, astaxanthin becomes associated with HDL parti-
cles [48] in the blood, where the skin and gonads take
some of it up, and the rest is metabolized by the liver [38].
The above explanation suggests that muscle functions as
an astaxanthin 'sink' in the sea and as a 'source' in the
river.
Discussion
The model draws upon the general biochemistry of caro-
tenoids, fish physiology and fatty acid metabolism in ver-
tebrates and is capable of mimicking key experiments.
One may object that this capability is not due to a valid
representation of the system, but is caused by the lack of
experimental data giving too much freedom in the choice
of parameter values. However, what we have provided
here is not a high-resolution prediction machine, but a
typical representative of an early-phase model where the
experimental data allows the construction of a tentative
model, but does not permit extensive confirmation of
underlying premises and parameter values. The heuristic
value of such models should not be underestimated. The
development as well as the subsequent analysis of models
of this type are very instrumental for identifying which
assumptions need closer experimental attention and
which kind of data that should be collected in order to get
a more solid and comprehensive understanding of the
system. For example, from the sensitivity analysis it can be
seen that the muscle uptake process needs to be under-
stood and quantified in a more explicit manner.
Elucidating the regulatory pathways and processes under-
lying a complex polygenic trait and finding the genetic
polymorphisms that are responsible for observed pheno-
typic variation are two major challenges currently con-
fronting production biology and biomedicine. We have
shown that a mathematical model may contribute sub-
stantially to both aspects by integrating available empiri-
cal data into a concerted whole, by identifying which
processes are most sensitive to variation in parameter val-
ues and by identifying those that are not likely to be under
strict regulatory control.
Conclusion
We have translated the available knowledge of carotenoid
metabolism in vertebrates into a specific dynamic model
of astaxanthin uptake, transport, utilization and metabo-
lism in Atlantic salmon. The model provides a theoretical
framework for a quantitative understanding of the factors
underlying observed phenotypic variation in flesh carote-
noid concentration. It identifies the uptake process over
the muscle membrane as a potentially important source
of variation. It predicts that there is no specific regulatory
system for the release of astaxanthin from the muscle cells
into the blood stream. Finally, the model provides a scaf-
fold for modelling carotenoid metabolism in other verte-
brate systems for epistemic as well as instrumental
purposes.
Methods
The model
The uptake, transport and deposition of astaxanthin in the
salmon was modelled as a function of the feed input and
the feeding frequency from when the fish is around 100
grams, until it is slaughtered at day N. The dimension of
the time unit t is denoted as tu, which can be either hours
or days depending on the simulations.
The intake of astaxanthin is a function of the amount of
astaxanthin in the feed Af (dimension-mg·(kg feed)-1) and
the feed intake Fi (kg feed·tu-1). In a domesticated situa-
tion, the feed intake is in turn a function of the weight of
the fish FW (kg), the feeding frequency Ff (tu-1) and the
Feed Conversion Ratio FCR. The rate of intake of astaxan-
thin Iax(t) (mg·tu-1) can then be described by the function
Iax(t) = Af Fi(FWT, Ff, FCR).
The weight of the fish FWT at the beginning of a given day
T, T ∈ {0, 1,...N}, is stipulated by use of specific growth
rate SGR data;
where SGRT the specific growth rate at day T and is empir-
ically obtained [49]. To get a correspondence between the
algebraic weight equation and the continuous differential
equations model presented below, weight at time t (W(t))
is defined as the weight at the end of the previous day, i.e.
W(t) = FWT.
In order to express state variables and parameters as per
ml blood, per kg liver or per kg muscle, we assumed the
blood volume (Bv(t)), the liver weight (Lw(t)), and the
FW FW
SGR
TT
T =+ 




 −1 1
100
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muscle weight (Mw(t)) to make up approximately 4.5%,
1% and 50% of the total fish weight, respectively [50,51].
(The tissue weights are related to the overall body weight
by the allometric relationships: Bv(t) = bW(t)γ,  Lw(t) =
lW(t)λ and Mw(t) = mW(t)ρ, with γ, λ and ρ usually not
being equal to 1, but the error being considered negligible
here, we set them as 1).
a. Ordinary differential equations
Mathematical modelling by ordinary differential equa-
tions (ODEs) is a standard means to describe and analyse
dynamic biological processes in continuous time, e.g. [52-
55]. Here, the flow and uptake of astaxanthin through the
system is represented using eight ordinary differential
equations. The linear uptake and transport terms in the
equations contain rates (denoted by small r) that have a
dimension of tu-1.
The relative rate of change of the concentration of astaxan-
thin bound to chylomicrons in the blood stream (Xcm(t)),
is dependent upon the flow of astaxanthin through the
intestinal wall, the rate of uptake of astaxanthin from the
chylomicron surface by serum albumin, and the rate of
LPL-mediated release of astaxanthin (which is taken up by
muscle as well as causing creation of chylomicron rem-
nants) and is given by
Here, rc is the bioavailable fraction of provided astaxan-
thin. Due to the time delay between feeding and the astax-
anthin actually entering the intestine, Iaxi(t), the pigment
entering the intestinal lumen at time t, is expressed as a
convolution of the astaxanthin in the feed and the func-
tion  Z  (integral kernel), i.e.
. The convolution is used in
order to represent the distributed time delay of astaxan-
thin between when it enters the intestine to when it finally
diffuses into the intestinal lumen. For the sake of conven-
ience, we assume Iaxi and Z to be Gaussian functions with
means µ1, µ2 and standard deviations σ1, σ2, respectively.
While Iaxi is assumed to have a small deviation, the mean
of the integral kernel Z determines the length of the time
delay and the deviation determines the spread. The con-
volution function Iaxi is then another Gaussian of the form
The parameter rhc expresses the rate at which a fraction φ,
(0 ≤ φ = 1) of chylomicron-bound astaxanthin is taken up
by serum albumin as well as the rate at which the remain-
ing fraction is converted to chylomicron remnants-bound
astaxanthin. Both occur due to the activity of LPL.
The relative rate of change of the concentration of astaxan-
thin bound to chylomicron remnants (Xcmr(t)) is then
given by the fraction (1-φ) of the rate loss term that ends
up in chylomicron remnants, minus the liver uptake rate
of the remnants;
Here rlc is the relative rate of uptake in liver.
The relative rate of change in the amount of astaxanthin
in the blood bound to serum albumin (Xa(t)) is depend-
ent on the uptake of astaxanthin from chylomicrons,
VLDL and LDL, minus the rate of albumin-mediated dep-
osition of astaxanthin in liver and muscle tissues;
Here, rhv and ral are the relative rates of uptake from VLDL
and LDL, respectively, and rla is the relative rate of deposi-
tion in the liver. The parameter Rma (mg·(ml blood)-1·tu-1)
is the maximum relative rate of astaxanthin deposition in
the muscle, which is a saturable process and is represented
by the sigmoid function Sma [32]. The parameter η  is
explained below.
The relative rate of change of the amount of astaxanthin
in the liver (Xl(t)) is dependent on the uptake from blood
(from chylomicron remnants, LDL, HDL and albumin),
the rate of metabolism in the liver, and the rate of produc-
tion of VLDL-bound astaxanthin transported back into
the blood stream;
where rlh is the relative rate of HDL-bound astaxanthin
uptake by the liver, rld is the relative rate of astaxanthin
degradation in the liver, and rv is the relative rate of trans-
port of astaxanthin by VLDL into the blood.
The relative rate of change of the concentration of VLDL-
bound astaxanthin in the blood stream (Xvldl(t)) is
dependent on the amount delivered by the liver, the rate

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of conversion into LDL, the uptake by albumin, and the
transfer of astaxanthin to HDL;
where rhv is the relative rate of conversion of VLDL-bound
astaxanthin into LDL-bound astaxanthin as well as the
accompanying uptake into the albumin, due to LPL
hydrolysis. The fraction of VLDL astaxanthin that is taken
up by albumin is represented by η, (0 ≤ η ≤ 1). The param-
eter rhvldl is the transfer of astaxanthin to HDL by the action
of CETP.
The relative rate of change of astaxanthin concentration in
LDL (Xldl(t)) is expressed in terms of the conversion of
VLDL-bound astaxanthin into LDL, the uptake into albu-
min at the muscle, the transfer into HDL and the uptake
into the liver;
where ral is the relative rate of astaxanthin uptake in the
muscle and rhldl is the relative transfer rate into HDL due
to CETP activity.
The relative rate of change of astaxanthin concentration in
HDL (Xhdl(t)) is represented as the transfer of astaxanthin
from VLDL and LDL, the uptake into the muscle during
maturation and the delivery of astaxanthin to the liver;
where rhm is the relative rate of uptake of astaxanthin from
the muscle and Hsexmat denotes the status of sexual matu-
ration of the salmon. It has a value of 0 in an immature
fish and 1 in a sexually mature one.
The relative rate of change of concentration of astaxanthin
bound to muscle (Xm(t)) is equal to the rate of astaxanthin
taken up from the blood via the albumin minus the rate
of active transport out of the muscle by the HDL, to
gonads and skin;
where the relative transport rate of astaxanthin out of the
muscle rhm is dependent on the rate of degradation in the
muscle.
b. Sexual maturation and spawning migration
In order to test the hypothesis behind the life history rea-
soning, we add two new variables to represent astaxanthin
concentration in the skin (Xs(t)) and gonads (Xg(t) during
spawning migration. The variable Hsexmat is now set to 1,
enabling the flow of astaxanthin from the muscle into the
HDL, and from there into the skin and gonads. The frac-
tion of pigment redistributed to the gonads is represented
as ω, the rest of which (1-ω) goes to the skin. The HDL
equation is changed into:
Two new equations are added to represent skin and gonad
uptake;
Calibration of the model/constraints to be accounted for
Though the values for most of the parameters of the
model are still unknown, the significant amount of
research done in the area of pigment deposition in salmo-
nids provided a number of constraints for the model. We
know that the optimal astaxanthin dietary content for
Atlantic salmon is around 60 mg/kg feed [8] out of which
only around 15% is retained in the flesh [56]. The mean
carotenoid content in salmon muscle is around 7 mg/kg,
though higher values have been observed as well. The
uptake from the intestine into the blood takes between 18
to 30 hrs [18,19], with the maximum carotenoid concen-
tration in the blood occurring around 30 hrs. In the
blood, about 50% is attached to serum albumin com-
pared to the lipoproteins [12].
There is a metabolic reduction and degradation in the
liver [57]. The uptake into the liver is saturable but only at
very high doses [29].
The uptake in the muscle cells is saturable [43] and the
astaxanthin level is not affected by starvation up to 85
days in the immature fish [36,37], indicating a negligible
degradation.
In the sexually mature fish, the total whole-body caroten-
oid content of females and males were 73–79% and 18–
19% of that in the immature fish, respectively [38]. In
males the skin content increased strongly while in females
the pigment levels in the gonads and eggs increased.
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Using these constraints, as well as those provided by the
experimental data, we assigned values to the different
parameters (Table 1).
Given the fact that our experimental data has two different
time scales (hours and days) as well as various other dif-
ferences in the experimental set-up (temperature, fish
weight, feed etc.) we do not perform any specific compu-
tational fitting procedures on it. At this stage, such an exer-
cise would not reveal anything of significance as regards to
the model setup. Later, the model will be refined to deal
with specific sub-systems (e.g. muscle uptake) and in that
case we will carry out more rigorous parameter estima-
tions.
Sensitivity analysis – QSS
Setting the derivatives of the model equations equal to
zero, we arrive at a number of easy-to-solve linear equa-
tions and one equation that is not generally solvable, the
equation for the QSS level of astaxanthin in albumin;
Axa + Sma(xa;1) = BIaxi, (1)
where xa = Xa/θma is the albumin astaxanthin level relative
to the threshold of muscle uptake and
The relationship between the meta-parameters A and B
and the solution xa of Eq. (1) is examined analytically. By
implicit differentiation of this equation we find that xa
increases with B and decreases with A (when A and B are
fixed, respectively). As Sma is a monotonically increasing
function of xa, y = Sma(xa;1) is also increasing with B and
decreasing with A. Below we investigate the sensitivity of
the muscle uptake rate (MUR) RmaSma(xa;1) to variation in
the parameters that constitute A and B. For each chosen
parameter P, all other parameters are fixed to their values
from the multiple-feeding experiment, and we consider
the values P = 2k P0, k = -n,.., -1, 0, 1,.., n where P0 is the
value of P given in Table 1. As a result, a profile represent-
ing the sensitivity of the MUR to variation in the chosen
parameter is obtained.
a. Liver uptake rate rla and intestinal uptake rate rc
We note from Eq. (2) that A and rla as well as B and rc are
proportional. This suggests that the MUR is increasing
with rc and decreasing with rla (Figures 4A and 4B).
b. Liver metabolism rate rld and uptake rate rll
The meta-meta-parameter α is positively related to A and
negatively related to B enabling us to conclude that the
solution xa as well as MUR decrease with α. Due to the
hyperbolic relationship between the liver metabolism rate
rld and α, the MUR thus decreases with rld. Moreover α is a
decreasing function of another meta-meta-parameter, β,
which is a slightly decreasing function of the liver uptake
rate rll. Thus, since α increases with rll, the MUR decreases
with rll. The negative relationship between the MUR and rll
and rld is depicted in Figure 4C and 4D, respectively.
From Figures 4C and 4D we observe that the decrease of
the MUR with increasing rll and rld is negligible (note the
scaling of the vertical axis). This is due to the following:
Variation in rll causes minute changes in the MUR since
whether rll is zero or infinite, β remains within a narrow
subinterval (how  narrow is of course parameter value
dependent) of [0, 1]. In turn, α, and to an even larger
extent, the MUR, are virtually unaffected by changes in rll.
Similarly, since α is also confined to the unit interval, A
and B cannot attain values outside the intervals [0, rla/Rma]
and [φrc/(RmaBvθma), rc/(RmaBvθma)], respectively. Thus for
a wide range of parameter values we expect that the sensi-
tivity of the MUR to variation in rld is also small. We note
that the liver uptake rates rlc and rlh do not affect the QSS
of xa at all; hence the MUR is independent of these rates.
c. Muscle uptake rate Rma and threshold θma
Both meta-parameters A and B are inversely related to the
maximum muscle uptake rate Rma. Using implicit differ-
entiation we conclude that xa is decreasing with Rma. In
contrast, the derivative of y = RmaSma(xa;1) with respect to
Rma is positive;
i.e. the MUR is an increasing function of Rma (Figure 4E).
Finally, the muscle uptake threshold θma and B are nega-
tively related, hence the MUR decreases with θma (Figure
4F).
Sensitivity analysis – time-series
The sensitivity analysis on the single pulse feeding data
was performed by varying the 17 individual parameter
values (all the rates and the µ2 and σ2 terms of the integral
kernel Iaxi) over a uniformly distributed interval centred
on the values given in Table 1. Following simulation of
the model with the random values, the overall relative
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sum of squared deviations from the experimental data
was calculated as well as the relative deviation at each
experimental time point. The simulations were performed
50,000 times and we chose those parameter sets which
gave an output having a total deviation of 30% or less
from the experimental data, as well as a relative deviation
of 50% or less at each individual experimental time point.
The range of values for each individual parameter in the
selected parameter sets (1,264) were then plotted sepa-
rately (Figure 5A). As can be seen from the figure, the
parameters rc and the mean µ2 and standard deviation σ2
of the integral kernel have the smallest range. The distri-
bution of these three values is not uniform (Figure 5B)
even though the original variation was drawn from a uni-
form distribution. However, even for this selected set of
parameter values giving the best fit, the distribution of the
rest of the 14 parameters is approximately uniform and
thus of no interest to us. The ratio of these three parame-
ters to the rest was calculated for all the selected sets, as
well as for the total 50,000 simulations. There is a signifi-
cant narrowing in the range of values giving a good fit, for
the interaction between rc and µ2 (Figure 5C) as well as for
the ratio between µ2 and σ2 (Figure 5D).
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